(Q34204139)

31 July 2017

title

Characterizing aggressiveness and predicting future progression of CF lung disease (English)

1 reference

31 July 2017

Michael W Konstan

1

1 reference

31 July 2017

Jeffrey S Wagener

series ordinal

2

1 reference

31 July 2017

Donald R VanDevanter

series ordinal

3

1 reference

31 July 2017

publication date

1 June 2009

1 reference

Journal of Cystic Fibrosis

31 July 2017

published in

1 reference

31 July 2017

volume

8 Suppl 1

1 reference

31 July 2017

page(s)

S15-9

1 reference

Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Effect of high-dose ibuprofen in patients with cystic fibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Factors influencing outcomes in cystic fibrosis: a center-based analysis.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167362

Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis

28 October 2018

1 reference

12 December 2020

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

12 December 2020

1 reference

12 December 2020

Identifying treatments that halt progression of pulmonary disease in cystic fibrosis

1 reference

12 December 2020

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

1 reference

12 December 2020

High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial

1 reference

12 December 2020

10.1016/S1569-1993(09)60006-0

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference